Skip to main content
COSMAX, INC. logo

COSMAX, INC. — Investor Relations & Filings

Ticker · 192820 ISIN · KR7192820009 LEI · 988400ZU10J4AP3M4Y14 KO Manufacturing
Filings indexed 625 across all filing types
Latest filing 2023-05-16 Regulatory Filings
Country KR South Korea
Listing KO 192820

About COSMAX, INC.

https://www.cosmax.com/

COSMAX, INC. is a global research, development, and manufacturing company specializing in cosmetics and health functional foods. As a leading Original Design Manufacturer (ODM), it provides comprehensive, science-backed services across the entire product pipeline, from formulation and ingredient development to full-scale production. The company supports a diverse portfolio of hundreds of global brands, leveraging a network of advanced research and production facilities. With a significant focus on innovation, its large research team develops a wide range of products, including skincare, makeup, and dietary supplements, for its international clientele.

Recent filings

Filing Released Lang Actions
투자판단관련주요경영사항(특허권 취득)
Regulatory Filings Classification · 1% confidence The document is a regulatory filing from Cosmax regarding the acquisition of a patent ('특허권 취득'). It follows the standard format for 'Major Management Matters' (주요경영사항) in the Korean market, which is used to disclose significant corporate events that do not fall into specific financial reporting categories like earnings or dividends. Since it is a general regulatory disclosure of a business event, it fits best under the 'Regulatory Filings' category.
2023-05-16 Korean
분기보고서 (2023.03)
Interim / Quarterly Report Classification · 1% confidence The document is a 'Quarterly Report' (분기보고서) for the company COSMAX (코스맥스) covering the period from January 1, 2023, to March 31, 2023. It contains detailed financial statements, business operations, and management analysis, which aligns with the definition of an Interim/Quarterly Report (IR). Q1 2023
2023-05-15 Korean
연결재무제표기준영업(잠정)실적(공정공시)
Earnings Release Classification · 1% confidence The document is a 'Preliminary Earnings Report' (영업(잠정)실적) for Cosmax, detailing quarterly financial performance (revenue, operating profit, net income) for Q1 2023. It is a standard regulatory disclosure of financial results, which fits the definition of an Earnings Release (ER). Q1 2023
2023-05-12 Korean
투자판단관련주요경영사항(특허권 취득)
Regulatory Filings Classification · 1% confidence The document is a regulatory filing from Cosmax regarding the acquisition of a patent ('특허권 취득'). It follows the standard format for 'Major Management Matters' (주요경영사항) in the Korean market, which is used to disclose significant corporate events that do not fall into specific categories like financial reports or M&A. Since it is a general regulatory disclosure of a business event, it fits best under the 'Regulatory Filings' category.
2023-04-24 Korean
투자판단관련주요경영사항(특허권 취득)
Regulatory Filings Classification · 1% confidence The document is a regulatory filing from Cosmax regarding the acquisition of a patent ('특허권 취득'). It follows the standard format for 'Major Management Matters' (주요경영사항) in the Korean market, which is used to disclose significant corporate events that do not fall into specific categories like financial reports or M&A. Since it is a general regulatory disclosure of a business event, it fits best under the 'Regulatory Filings' category.
2023-04-24 Korean
투자판단관련주요경영사항(특허권 취득)
Regulatory Filings Classification · 1% confidence The document is a regulatory filing from Cosmax regarding the acquisition of a patent ('특허권 취득'). It follows the standard format for 'Major Management Matters' (주요경영사항) in the Korean market, which is used to disclose significant corporate events that do not fall into specific categories like financial reports or M&A. Since it is a general regulatory disclosure of a business event, it fits best under the 'Regulatory Filings' category.
2023-04-14 Korean

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.